Forekomsten af dødsfald var dog højere hos olanzapin- behandlede patienter end hos patienter, behandlet med placebo, uafhængig af disse risikofaktorer.
However, the incidence of death was higher in olanzapine-treated than in placebo-treated patients independent of these risk factors.